Insider · CIK 0001391070

Kollins John A

Reports to the SEC for 3 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001391070

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−175K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−505K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−240K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−128K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−128K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−128K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−277K sh	—	—	0
2023-06-06	Satsuma Pharmaceuticals, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−306K sh	$0.91	−$278K	0
2022-06-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+505K sh	—	—	505,000
2020-12-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+240K sh	—	—	240,000
2020-03-04	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+175K sh	—	—	175,000
2014-10-30	Paratek Pharmaceuticals, Inc.A Award	SVP, Chief Business Officer	AAward	+4,161 sh	$21.59	+$89.8K	4,161
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	SVP, Chief Business Officer	DDisposition to Issuer	−7,083 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	SVP, Chief Business Officer	DDisposition to Issuer	−4,166 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	SVP, Chief Business Officer	DDisposition to Issuer	−9,583 sh	—	—	0
2014-10-30	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	SVP, Chief Business Officer	DDisposition to Issuer	−7,500 sh	—	—	0
2013-07-15	Paratek Pharmaceuticals, Inc.Common Stock Option (right to buy)A Award	SVP, Chief Business Officer	AAward	+115K sh	—	—	115,000
2013-01-07	Paratek Pharmaceuticals, Inc.Common Stock Option (right to buy)A Award	SVP, Chief Business Officer	AAward	+90K sh	—	—	90,000
2012-06-20	Paratek Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	SVP, Chief Business Officer	AAward	+85K sh	—	—	85,000
2009-01-20	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000

Recent filings

Accepted (ET)
Jun 84
Kollins John A0000899243-23-014879
SEC(opens sec.gov)
Jun 74
Kollins John A0001567619-22-012477
SEC(opens sec.gov)
Dec 74
Kollins John A0001567619-20-020717
SEC(opens sec.gov)
Mar 64
Kollins John A0001567619-20-005798
SEC(opens sec.gov)
Oct 304
Transcept Pharmaceuticals Inc0001181431-14-035070
SEC(opens sec.gov)
Jul 184
Transcept Pharmaceuticals Inc0001181431-13-040633
SEC(opens sec.gov)
Jan 84
Kollins John A0001181431-13-002493
SEC(opens sec.gov)
Jun 214
Kollins John A0001181431-12-037553
SEC(opens sec.gov)
Jan 224
OXIGENE INC0001181431-09-004238
SEC(opens sec.gov)

Companies

Address

C/O OXIGENE, INC., 230 THIRD AVENUE

WALTHAM, MA, 02451